[Clinico-biological classification of systemic lupus].
Anti-nuclear and anti-cytoplasmic antibodies are found in nearly 99% of systemic lupus erythematosus (SLE) patients. Among the different antibodies described, 2 are highly specific for SLE although their frequencies differ considerably. Anti-dsDNA (anti-native DNA) antibodies are detected at some point during disease evolution in 65-95% of the patients, whereas anti-Sm antibodies occur in only 7-30% of the cases, with wide variations according to race and geographical origin. The present study attempts to correlate specific clinical manifestations as a function of certain antibodies: SLE with anti-U1 RNP, with or without anti-dsDNA; SLE with anti-histones; SLE with anti-Ro (SS-A); SLE with anti-phospholipid antibodies or anti-type 5 mitochondrial antibodies; and SLE with anti-ribosomal antibodies. The diversity of these clinical-biological subgroups tends to imply that SLE is a syndrome rather than a distinct disease state.